Metabolomic biosignature differentiates melancholic depressive patients from healthy controls

BACKGROUND: Major depressive disorder (MDD) is a heterogeneous disease at the level of clinical symptoms, and this heterogeneity is likely reflected at the level of biology. Two clinical subtypes within MDD that have garnered interest are “melancholic depression” and “anxious depression”. Metabolomi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Genomics
Glavni autori: Liu, Yashu, Yieh, Lynn, Yang, Tao, Drinkenburg, Wilhelmus, Peeters, Pieter, Steckler, Thomas, Narayan, Vaibhav A., Wittenberg, Gayle, Ye, Jieping
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Methodology Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4994306/
https://ncbi.nlm.nih.gov/pubmed/27549765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12864-016-2953-2
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items